Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Matthias Skowron"'
Autor:
Frank Berthold, Barbara Hero, Karen Ernestus, Patrick Warnat, Harald Voth, Matthias Skowron, Yvonne Kahlert, Benedikt Brors, André Oberthuer, Matthias Fischer
Supplementary Table 2 from Differential Expression of Neuronal Genes Defines Subtypes of Disseminated Neuroblastoma with Favorable and Unfavorable Outcome
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4056f24db2cadf5206d2bce82e590f5f
https://doi.org/10.1158/1078-0432.22441648.v1
https://doi.org/10.1158/1078-0432.22441648.v1
Autor:
Frank Berthold, Barbara Hero, Karen Ernestus, Patrick Warnat, Harald Voth, Matthias Skowron, Yvonne Kahlert, Benedikt Brors, André Oberthuer, Matthias Fischer
Supplementary Table 1 from Differential Expression of Neuronal Genes Defines Subtypes of Disseminated Neuroblastoma with Favorable and Unfavorable Outcome
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a0e399d3806e46505f78a6d2bf0b25c
https://doi.org/10.1158/1078-0432.22441651.v1
https://doi.org/10.1158/1078-0432.22441651.v1
Autor:
Frank Berthold, Barbara Hero, Karen Ernestus, Patrick Warnat, Harald Voth, Matthias Skowron, Yvonne Kahlert, Benedikt Brors, André Oberthuer, Matthias Fischer
Supplementary Table 3 from Differential Expression of Neuronal Genes Defines Subtypes of Disseminated Neuroblastoma with Favorable and Unfavorable Outcome
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::120c8e84aa6fe18b971a441c1aba89e8
https://doi.org/10.1158/1078-0432.22441645
https://doi.org/10.1158/1078-0432.22441645
Autor:
Harald Voth, Karen Ernestus, Barbara Hero, Yvonne Kahlert, André Oberthuer, Benedikt Brors, Matthias Skowron, Patrick Warnat, Frank Berthold, Matthias Fischer
Publikováno v:
Clinical Cancer Research. 12:5118-5128
Purpose: Identification of molecular characteristics of spontaneously regressing stage IVS and progressing stage IV neuroblastoma to improve discrimination of patients with metastatic disease following favorable and unfavorable clinical courses. Expe
Autor:
André Oberthuer, Matthias Fischer, Kathrin Mehler, Yvonne Kahlert, Frank Westermann, Frank Berthold, Matthias Skowron, Rüdiger Spitz
Publikováno v:
Gene. 363:41-50
Genetic aberrations in neuroblastoma (NB) have been extensively characterized over the last years. Alterations of the short arm of chromosome 2 (2p) have been of particular interest, since amplification of the MYCN oncogene on 2p24 is associated with
Autor:
Marc Boensch, André Oberthuer, Matthias Skowron, Ruediger Spitz, Matthias Fischer, Joern Oestreich, Frank Berthold
Publikováno v:
Diagnostic Molecular Pathology. 14:177-182
Amplification of the oncogene MYCN as well as deletions in 1p and 11q are important prognostic and in part therapy-stratifying factors in human neuroblastoma. Due to the increasing clinical relevance of these molecular markers, accurate and fast asse
Autor:
Benedikt Brors, Matthias Fischer, André Oberthuer, A Fagin, Frank Berthold, H Voth, Frank Westermann, S Nowacki, Barbara Hero, Matthias Skowron, Angelika Eggert
Publikováno v:
Oncogene. 27(23)
Cell adhesion molecule 1 (CADM1) is a putative tumour suppressor gene, which is downregulated in many solid tumours. In neuroblastoma, loss of CADM1 expression has recently been found in disseminated tumours with adverse outcome, prompting us to inve
Publikováno v:
The Journal of molecular diagnostics : JMD. 7(1)
Real-time reverse transcriptase-polymerase chain reaction (RT-PCR) represents a sensitive and efficient technique to determine expression levels of target genes in multiple samples and is increasingly used in clinical oncology to evaluate the patient
Publikováno v:
European journal of cancer (Oxford, England : 1990). 40(18)
While the role of MYCN-amplification (MNA) for risk assessment in neuroblastoma is undisputed, the phenomenon of gene copy excess below the amplification threshold is rarely described. To discuss biological characteristics and the clinical impact of